Browse By



  • Viruses


  • Gene region


  • Methylation status


  • Disease type


  • Total number of Results for Hypo are 1938
    Results from 0 - 25

    ViralrpiIDVirus nameGene regionCpG islandMethylation start positionMethylation stop positionMethylation statusMethylation percentageSample sourceSample typeSample sizeDiseaseDetection techniquePMID
    ViraEpi01
    Epstein barr virus (EBV)
    Qp
    NA
    62208
    62208
    Hypo
    33.33%
    EBL specimens
    EBL 1 tumor sample
    6 colonies sequenced
    Endemic Burkitt Lymphoma (EBL)
    Bisulfite seq
    9696800
    ViraEpi02
    Epstein barr virus (EBV)
    Qp
    NA
    62222
    62222
    Hypo
    16.66%
    EBL specimens
    EBL 1 tumor sample
    6 colonies sequenced
    Endemic Burkitt Lymphoma (EBL)
    Bisulfite seq
    9696800
    ViraEpi03
    Epstein barr virus (EBV)
    Qp
    NA
    62227
    62227
    Hypo
    16.66%
    EBL specimens
    EBL 1 tumor sample
    6 colonies sequenced
    Endemic Burkitt Lymphoma (EBL)
    Bisulfite seq
    9696800
    ViraEpi25
    Epstein barr virus (EBV)
    Qp
    NA
    62254
    62254
    Hypo
    11.11%
    EBL specimens
    EBL 2 tumor sample
    9 colonies sequenced
    Endemic Burkitt Lymphoma (EBL)
    Bisulfite seq
    9696800
    ViraEpi26
    Epstein barr virus (EBV)
    Qp
    NA
    62272
    62272
    Hypo
    11.11%
    EBL specimens
    EBL 2 tumor sample
    9 colonies sequenced
    Endemic Burkitt Lymphoma (EBL)
    Bisulfite seq
    9696800
    ViraEpi27
    Epstein barr virus (EBV)
    Qp
    NA
    62275
    62275
    Hypo
    11.11%
    EBL specimens
    EBL 2 tumor sample
    9 colonies sequenced
    Endemic Burkitt Lymphoma (EBL)
    Bisulfite seq
    9696800
    ViraEpi28
    Epstein barr virus (EBV)
    Qp
    NA
    62282
    62282
    Hypo
    11.11%
    EBL specimens
    EBL 2 tumor sample
    9 colonies sequenced
    Endemic Burkitt Lymphoma (EBL)
    Bisulfite seq
    9696800
    ViraEpi32
    Epstein barr virus (EBV)
    Qp
    NA
    62398
    62398
    Hypo
    22.22%
    EBL specimens
    EBL 2 tumor sample
    9 colonies sequenced
    Endemic Burkitt Lymphoma (EBL)
    Bisulfite seq
    9696800
    ViraEpi41
    Epstein barr virus (EBV)
    Qp
    NA
    62208
    62208
    Hypo
    40%
    EBL specimens
    EBL 3 tumor sample
    5 colonies sequenced
    Endemic Burkitt Lymphoma (EBL)
    Bisulfite seq
    9696800
    ViraEpi122
    Epstein barr virus (EBV)
    Qp
    NA
    62222
    62222
    Hypo
    25%
    EBL specimens
    EBL 8 tumor sample
    4 colonies sequenced
    Endemic Burkitt Lymphoma (EBL)
    Bisulfite seq
    9696800
    ViraEpi141
    Epstein barr virus (EBV)
    Qp
    NA
    62208
    62208
    Hypo
    25%
    EBL specimens
    EBL 10 tumor sample
    4 colonies sequenced
    Endemic Burkitt Lymphoma (EBL)
    Bisulfite seq
    9696800
    ViraEpi182
    Epstein barr virus (EBV)
    Qp
    NA
    62222
    62222
    Hypo
    25%
    Tumor sample
    NPC2 tumor sample
    4 colonies sequenced
    Nasopharangeal carcinoma (NPC)
    Bisulfite seq
    9696800
    ViraEpi261
    Epstein barr virus (EBV)
    Qp
    NA
    62208
    62208
    Hypo
    33.33%
    Hodgkin disease specimens
    HD2 tumor sample
    6 colonies sequenced
    Hodgkin disease (HD)
    Bisulfite seq
    9696800
    ViraEpi262
    Epstein barr virus (EBV)
    Qp
    NA
    62222
    62222
    Hypo
    33.33%
    Hodgkin disease specimens
    HD2 tumor sample
    6 colonies sequenced
    Hodgkin disease (HD)
    Bisulfite seq
    9696800
    ViraEpi263
    Epstein barr virus (EBV)
    Qp
    NA
    62227
    62227
    Hypo
    33.33%
    Hodgkin disease specimens
    HD2 tumor sample
    6 colonies sequenced
    Hodgkin disease (HD)
    Bisulfite seq
    9696800
    ViraEpi265
    Epstein barr virus (EBV)
    Qp
    NA
    62254
    62254
    Hypo
    33.33%
    Hodgkin disease specimens
    HD2 tumor sample
    6 colonies sequenced
    Hodgkin disease (HD)
    Bisulfite seq
    9696800
    ViraEpi267
    Epstein barr virus (EBV)
    Qp
    NA
    62275
    62275
    Hypo
    33.33%
    Hodgkin disease specimens
    HD2 tumor sample
    6 colonies sequenced
    Hodgkin disease (HD)
    Bisulfite seq
    9696800
    ViraEpi268
    Epstein barr virus (EBV)
    Qp
    NA
    62282
    62282
    Hypo
    16.66%
    Hodgkin disease specimens
    HD2 tumor sample
    6 colonies sequenced
    Hodgkin disease (HD)
    Bisulfite seq
    9696800
    ViraEpi279
    Epstein barr virus (EBV)
    Qp
    NA
    62449
    62449
    Hypo
    16.66%
    Hodgkin disease specimens
    HD2 tumor sample
    6 colonies sequenced
    Hodgkin disease (HD)
    Bisulfite seq
    9696800
    ViraEpi361
    Epstein barr virus (EBV)
    Qp
    NA
    62208
    62208
    Hypo
    28.57%
    EBV(+) BL cell line
    Rael cell line
    7 colonies sequenced
    Burkitt Lymphoma (BL)
    Bisulfite seq
    9696800
    ViraEpi363
    Epstein barr virus (EBV)
    Qp
    NA
    62227
    62227
    Hypo
    14.28%
    EBV(+) BL cell line
    Rael cell line
    7 colonies sequenced
    Burkitt Lymphoma (BL)
    Bisulfite seq
    9696800
    ViraEpi364
    Epstein barr virus (EBV)
    Qp
    NA
    62230
    62230
    Hypo
    28.57%
    EBV(+) BL cell line
    Rael cell line
    7 colonies sequenced
    Burkitt Lymphoma (BL)
    Bisulfite seq
    9696800
    ViraEpi408
    Epstein barr virus (EBV)
    Qp
    NA
    62282
    62282
    Hypo
    20%
    EBV(+) BL cell line
    Akata cell line
    5 colonies sequenced
    Burkitt Lymphoma (BL)
    Bisulfite seq
    9696800
    ViraEpi481
    Epstein barr virus (EBV)
    Wp
    NA
    13956
    13956
    Hypo
    8.33%
    Cell line
    B lymphocyte culture post 8 day infection
    12 clones
    NA
    Bisulfite seq, Methylation Specific PCR (MSP)
    16920819
    ViraEpi482
    Epstein barr virus (EBV)
    Wp
    NA
    13976
    13976
    Hypo
    8.33%
    Cell line
    B lymphocyte culture post 8 day infection
    12 clones
    NA
    Bisulfite seq, Methylation Specific PCR (MSP)
    16920819